Global Biosimilar Insulin Market Research Report 2017

August 2017 | 113 pages | ID: G3649B116C1EN
QYResearch

Abstracts

In this report, the global Biosimilar Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosimilar Insulin in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Biosimilar Insulin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Pfizer
• Biogenomics
• Eli Lilly
• Gan&Lee Pharmaceuticals
• Geropharm
• Julphar Gulf Pharmaceutical Industries
• Paras Biopharmaceuticals
• Samsung Bioepis
• Sedico
• Wockhardt
• Teva Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Rapid Acting Insulins
• Short Acting Insulins
• Intermediate Insulins
• Long Lasting Insulins

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Biosimilar Insulin for each application, including

• Hospital
• Clinic
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Biosimilar Insulin Market Research Report 2017

1 BIOSIMILAR INSULIN MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar Insulin
1.2 Biosimilar Insulin Segment by Type (Product Category)
  1.2.1 Global Biosimilar Insulin Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Biosimilar Insulin Production Market Share by Type (Product Category) in 2016
  1.2.3 Rapid Acting Insulins
  1.2.4 Short Acting Insulins
  1.2.5 Intermediate Insulins
  1.2.6 Long Lasting Insulins
1.3 Global Biosimilar Insulin Segment by Application
  1.3.1 Biosimilar Insulin Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Medical Center
1.4 Global Biosimilar Insulin Market by Region (2012-2022)
  1.4.1 Global Biosimilar Insulin Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Biosimilar Insulin (2012-2022)
  1.5.1 Global Biosimilar Insulin Revenue Status and Outlook (2012-2022)
  1.5.2 Global Biosimilar Insulin Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL BIOSIMILAR INSULIN MARKET COMPETITION BY MANUFACTURERS

2.1 Global Biosimilar Insulin Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Biosimilar Insulin Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Biosimilar Insulin Production and Share by Manufacturers (2012-2017)
2.2 Global Biosimilar Insulin Revenue and Share by Manufacturers (2012-2017)
2.3 Global Biosimilar Insulin Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Biosimilar Insulin Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biosimilar Insulin Market Competitive Situation and Trends
  2.5.1 Biosimilar Insulin Market Concentration Rate
  2.5.2 Biosimilar Insulin Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL BIOSIMILAR INSULIN CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Biosimilar Insulin Capacity and Market Share by Region (2012-2017)
3.2 Global Biosimilar Insulin Production and Market Share by Region (2012-2017)
3.3 Global Biosimilar Insulin Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL BIOSIMILAR INSULIN SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Biosimilar Insulin Consumption by Region (2012-2017)
4.2 North America Biosimilar Insulin Production, Consumption, Export, Import (2012-2017)
4.3 Europe Biosimilar Insulin Production, Consumption, Export, Import (2012-2017)
4.4 China Biosimilar Insulin Production, Consumption, Export, Import (2012-2017)
4.5 Japan Biosimilar Insulin Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Biosimilar Insulin Production, Consumption, Export, Import (2012-2017)
4.7 India Biosimilar Insulin Production, Consumption, Export, Import (2012-2017)

5 GLOBAL BIOSIMILAR INSULIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Biosimilar Insulin Production and Market Share by Type (2012-2017)
5.2 Global Biosimilar Insulin Revenue and Market Share by Type (2012-2017)
5.3 Global Biosimilar Insulin Price by Type (2012-2017)
5.4 Global Biosimilar Insulin Production Growth by Type (2012-2017)

6 GLOBAL BIOSIMILAR INSULIN MARKET ANALYSIS BY APPLICATION

6.1 Global Biosimilar Insulin Consumption and Market Share by Application (2012-2017)
6.2 Global Biosimilar Insulin Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL BIOSIMILAR INSULIN MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Biosimilar Insulin Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Pfizer Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Biogenomics
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Biosimilar Insulin Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Biogenomics Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Eli Lilly
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Biosimilar Insulin Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Eli Lilly Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Gan&Lee Pharmaceuticals
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Biosimilar Insulin Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Geropharm
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Biosimilar Insulin Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Geropharm Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Julphar Gulf Pharmaceutical Industries
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Biosimilar Insulin Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Paras Biopharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Biosimilar Insulin Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Paras Biopharmaceuticals Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Samsung Bioepis
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Biosimilar Insulin Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Samsung Bioepis Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Sedico
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Biosimilar Insulin Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Sedico Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Wockhardt
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Biosimilar Insulin Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Wockhardt Biosimilar Insulin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Teva Pharmaceuticals

8 BIOSIMILAR INSULIN MANUFACTURING COST ANALYSIS

8.1 Biosimilar Insulin Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biosimilar Insulin

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Biosimilar Insulin Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biosimilar Insulin Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL BIOSIMILAR INSULIN MARKET FORECAST (2017-2022)

12.1 Global Biosimilar Insulin Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Biosimilar Insulin Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Biosimilar Insulin Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Biosimilar Insulin Price and Trend Forecast (2017-2022)
12.2 Global Biosimilar Insulin Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Biosimilar Insulin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Biosimilar Insulin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Biosimilar Insulin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Biosimilar Insulin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Biosimilar Insulin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Biosimilar Insulin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Biosimilar Insulin Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Biosimilar Insulin Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Insulin
Figure Global Biosimilar Insulin Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Biosimilar Insulin Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Rapid Acting Insulins
Table Major Manufacturers of Rapid Acting Insulins
Figure Product Picture of Short Acting Insulins
Table Major Manufacturers of Short Acting Insulins
Figure Product Picture of Intermediate Insulins
Table Major Manufacturers of Intermediate Insulins
Figure Product Picture of Long Lasting Insulins
Table Major Manufacturers of Long Lasting Insulins
Figure Global Biosimilar Insulin Consumption (K Pcs) by Applications (2012-2022)
Figure Global Biosimilar Insulin Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Global Biosimilar Insulin Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biosimilar Insulin Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Biosimilar Insulin Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Biosimilar Insulin Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Biosimilar Insulin Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Biosimilar Insulin Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Biosimilar Insulin Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Biosimilar Insulin Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Biosimilar Insulin Major Players Product Production (K Pcs) (2012-2017)
Table Global Biosimilar Insulin Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Biosimilar Insulin Production Share by Manufacturers (2012-2017)
Figure 2016 Biosimilar Insulin Production Share by Manufacturers
Figure 2017 Biosimilar Insulin Production Share by Manufacturers
Figure Global Biosimilar Insulin Major Players Product Revenue (Million USD) (2012-2017)
Table Global Biosimilar Insulin Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Biosimilar Insulin Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Biosimilar Insulin Revenue Share by Manufacturers
Table 2017 Global Biosimilar Insulin Revenue Share by Manufacturers
Table Global Market Biosimilar Insulin Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Biosimilar Insulin Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Biosimilar Insulin Manufacturing Base Distribution and Sales Area
Table Manufacturers Biosimilar Insulin Product Category
Figure Biosimilar Insulin Market Share of Top 3 Manufacturers
Figure Biosimilar Insulin Market Share of Top 5 Manufacturers
Table Global Biosimilar Insulin Capacity (K Pcs) by Region (2012-2017)
Figure Global Biosimilar Insulin Capacity Market Share by Region (2012-2017)
Figure Global Biosimilar Insulin Capacity Market Share by Region (2012-2017)
Figure 2016 Global Biosimilar Insulin Capacity Market Share by Region
Table Global Biosimilar Insulin Production by Region (2012-2017)
Figure Global Biosimilar Insulin Production (K Pcs) by Region (2012-2017)
Figure Global Biosimilar Insulin Production Market Share by Region (2012-2017)
Figure 2016 Global Biosimilar Insulin Production Market Share by Region
Table Global Biosimilar Insulin Revenue (Million USD) by Region (2012-2017)
Table Global Biosimilar Insulin Revenue Market Share by Region (2012-2017)
Figure Global Biosimilar Insulin Revenue Market Share by Region (2012-2017)
Table 2016 Global Biosimilar Insulin Revenue Market Share by Region
Figure Global Biosimilar Insulin Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Biosimilar Insulin Consumption (K Pcs) Market by Region (2012-2017)
Table Global Biosimilar Insulin Consumption Market Share by Region (2012-2017)
Figure Global Biosimilar Insulin Consumption Market Share by Region (2012-2017)
Figure 2016 Global Biosimilar Insulin Consumption (K Pcs) Market Share by Region
Table North America Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Biosimilar Insulin Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Biosimilar Insulin Production (K Pcs) by Type (2012-2017)
Table Global Biosimilar Insulin Production Share by Type (2012-2017)
Figure Production Market Share of Biosimilar Insulin by Type (2012-2017)
Figure 2016 Production Market Share of Biosimilar Insulin by Type
Table Global Biosimilar Insulin Revenue (Million USD) by Type (2012-2017)
Table Global Biosimilar Insulin Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Biosimilar Insulin by Type (2012-2017)
Figure 2016 Revenue Market Share of Biosimilar Insulin by Type
Table Global Biosimilar Insulin Price (USD/Pcs) by Type (2012-2017)
Figure Global Biosimilar Insulin Production Growth by Type (2012-2017)
Table Global Biosimilar Insulin Consumption (K Pcs) by Application (2012-2017)
Table Global Biosimilar Insulin Consumption Market Share by Application (2012-2017)
Figure Global Biosimilar Insulin Consumption Market Share by Applications (2012-2017)
Figure Global Biosimilar Insulin Consumption Market Share by Application in 2016
Table Global Biosimilar Insulin Consumption Growth Rate by Application (2012-2017)
Figure Global Biosimilar Insulin Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Pfizer Biosimilar Insulin Production Market Share (2012-2017)
Figure Pfizer Biosimilar Insulin Revenue Market Share (2012-2017)
Table Biogenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogenomics Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogenomics Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Biogenomics Biosimilar Insulin Production Market Share (2012-2017)
Figure Biogenomics Biosimilar Insulin Revenue Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Eli Lilly Biosimilar Insulin Production Market Share (2012-2017)
Figure Eli Lilly Biosimilar Insulin Revenue Market Share (2012-2017)
Table Gan&Lee Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gan&Lee Pharmaceuticals Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Production Market Share (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Revenue Market Share (2012-2017)
Table Geropharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Geropharm Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Geropharm Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Geropharm Biosimilar Insulin Production Market Share (2012-2017)
Figure Geropharm Biosimilar Insulin Revenue Market Share (2012-2017)
Table Julphar Gulf Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Production Market Share (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Revenue Market Share (2012-2017)
Table Paras Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Paras Biopharmaceuticals Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Production Market Share (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Revenue Market Share (2012-2017)
Table Samsung Bioepis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samsung Bioepis Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Production Market Share (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Revenue Market Share (2012-2017)
Table Sedico Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sedico Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sedico Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Sedico Biosimilar Insulin Production Market Share (2012-2017)
Figure Sedico Biosimilar Insulin Revenue Market Share (2012-2017)
Table Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Wockhardt Biosimilar Insulin Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Wockhardt Biosimilar Insulin Production Growth Rate (2012-2017)
Figure Wockhardt Biosimilar Insulin Production Market Share (2012-2017)
Figure Wockhardt Biosimilar Insulin Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Insulin
Figure Manufacturing Process Analysis of Biosimilar Insulin
Figure Biosimilar Insulin Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Insulin Major Manufacturers in 2016
Table Major Buyers of Biosimilar Insulin
Table Distributors/Traders List
Figure Global Biosimilar Insulin Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Insulin Price (Million USD) and Trend Forecast (2017-2022)
Table Global Biosimilar Insulin Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Biosimilar Insulin Production Market Share Forecast by Region (2017-2022)
Table Global Biosimilar Insulin Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Biosimilar Insulin Consumption Market Share Forecast by Region (2017-2022)
Figure North America Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Biosimilar Insulin Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Biosimilar Insulin Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Biosimilar Insulin Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Biosimilar Insulin Production (K Pcs) Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Biosimilar Insulin Revenue Market Share Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Price Forecast by Type (2017-2022)
Table Global Biosimilar Insulin Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Biosimilar Insulin Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source